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ABSTRACT 
 
BACKGROUND:The challenge to the prognosis of endodontic therapy 
lies on the quality of root canal fi lling. The zinc oxide eugenol  (ZOE) 
based sealers were introduced in Endodontics by Grossman  in 1936 
and they have been used in dentistry over a long period of time. It has 
been reported that  eugenol released from ZOE is an irritant  to the 
periapical tissues  and has cytotoxic properties . To overcome these 
disadvantages, there is a continued research for chemical compounds 
with better physical properties and more biocompatibility.  Ozone 
therapy has a long history of research and clinical application with 
humans because of its interesting biological properties.  
AIM:The aim of the study is to evaluate and compare the  physical  
properties and biocompatibili ty of zinc oxide - ozonated eugenol and 
conventional zinc oxide eugenol.  
MATERIALS AND METHODS:Following physical properties of 
conventional zinc oxide eugenol and zinc oxide-ozonated eugenol were 
evaluated and compared. [Group I :  Zinc oxide –  eugenol; Group II :  
Zinc oxide - ozonated eugenol].  Hardness of the mixed samples was 
measured using Shore hardness Durometer type A.Solubili ty was tested 
as a percentage of the mass of specimen removed from the distil led 
water compared with the original mass of the specimens using Mettler 
analytical balance.  pH of the fresh samples and the set samples were 
measured using calibrated pH meter after predetermined time intervals.  
Biocompatibility of the tested samples was  evaluated using the MTT 
tetrazolium reduction assay.  
RESULTS: The results of the present study have  shown that the 
hardness and solubil ity of the tested samples were almost similar in  
both the groups. pH and biocompatibility of the samples in Group II  
where eugenol is ozonated  was higher when compared to the samples in 
Group I. The proportional values obtained were statistically analysed 
by unpaired t -test.  
CONCLUSION: Within the limitations of the study, it  could be 
concluded that ozone with interesting biological  properties seems to be 
a better treatment modality in improving the properties of eugenol.  
However further clinical trials and randomized control  studies are 
required in this field to use ozonated eugenol in combination with zinc 
oxide powder to use it as an endodontic sealer invivo.  
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INTRODUCTION 
 
 Success in Endodontic therapy is based on diagnosis, treatment  
planning, knowledge of tooth anatomy and the traditional concepts of 
debridement and obturation. Schilder  describes the final objective of 
endodontic procedure as “the complete obturation of the root canal 
space”. It is the sealing of complex root canal system from the 
periodontal bone that ensures the health of attachment apparatus 
against the breakdown of endodontic origin ¹ .  
 
 Endodontic sealers are used in the obturation of root canal 
system to achieve a fluid tight seal  throughout the canal including the 
canal irregularities. An ideal root canal sealer should provide excellent 
seal when set, should have dimensional stability,  biocompatibility and 
help to resolve periapical lesions ² .  
  
 The Zinc Oxide Eugenol (ZOE) based sealers were introduced in 
Endodontics by Grossman  in 1936. ZOE sealers have a history of 
successful use over extended period  of t ime and has both anaesthetic 
and antimicrobial  properties ³ .  However the eugenol released from ZOE 
is reported to be an irritant to periapical tissues and said to have 
cytotoxic properties
4
.  Every attempt made to overcome these 
disadvantages and to replace ZOE completely has failed, so there is  
continued research for chemical compounds with better physical 
properties and biocompatibility.  
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 In search of other therapeutic modalities, ozone therapy has a 
long history of research and clinical applications with hum ans because 
of its interesting biological properties.  The word ozone was first  
introduced by Schonbein  in 1840 when he subjected oxygen to electric 
discharge and noted the odour of electric matter
5
.  Ozone is said to have 
antimicrobial, immune-modulatory,  immune-stimulating, anti -
inflammatory, analgesic and haemostatic property.  Ozonation is an 
energetic process that results in an oxygen molecule being split into 
singlet oxygen, the singlet oxygen then combines with diatomic oxygen 
to form ozone. Three systems of generating ozone are:  1.Ultraviolet  
system 2.Cold plasma system 3.Corona discharge system. The modes of 
applications of ozone can be in gaseous form, aqueous solution or in 
the form of ozonated oils.  
 
Antimicrobial action :  Being a superoxide, ozone i s 5 times more 
effective than chlorine. It  affects only the unhealthy cells such as 
cancer cells,  organisms like bacteria, viruses, fungi, parasites which 
have lost their protective mechanism and those devoid of anti -oxidants 
and free radical  scavengers.  
 
Anti-inflammatory and Analgesic action :  Ozone helps in the 
synthesis of biologically active substance such as interleukins, 
leukotriene and prostaglandins thereby reducing the inflammation and 
pain.  
 
Anti-cariogenic action :  The strongest naturally occurrin g acid 
produced by acidogenic bacteria is  pyruvic acid.  Ozone has the ability 
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to decarboxylate pyruvic acid to acetic acid and said to enhance the 
remineralisation of teeth.  
 
Antihypoxic action :  ozone brings about the rise of partial pressure of 
oxygen and acts as super oxygenator by bringing oxygen to tissues, 
assisting in its natural healing process
6
.  
 
 In dentistry,  ozonated oil  applied on herpes labialis infection and 
osteomyelitis  has demonstrated faster healing rate. It has been also 
used in the treatment of avascular osteonecrosis of the jaw. Ozone has 
strong bactericidal activity against plaque biofilm and can be used to 
disinfect  denture bases from Candida albicans. Zinc oxide -ozonated 
sesame oil when used as a root filling material has demonstrated  good 
success rate(93.3%) when compared to ZOE(63.3%)
7
.  In restorative 
dentistry, gaseous ozone has been used in the treatment of incipient 
lesions since it causes reduction in the number of microorganisms
8
.  In  
Endodontics, ozonated water had nearly the same antimicrobial activity 
as 2.5% NaOCl with fewer side effects when used as an irrigant
9
.   
   
 Ozonator D-400 uses a highly efficient corona discharge system 
rated at 400mg/hr. of constant ozone output. It can be used to ozonate 
water and oil. Due to the highly unstable nature of ozone in aqueous 
form, we opted use ozone in the form of oils.  Eugenol is a member of 
phenyl propanoids, a yellow oily liquid extracted especially from clove 
oil (80-85%), which can be ozonated to overcome its disadvantages 
like irritating action on periapical tissues and cytotoxic properties.  
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 Hence, the purpose of the study is to evaluate and compare the 
physical properties and biocompatibility of ozonated ZOE and 
conventional ZOE for being used as an endodontic sealer.  
 
Aim and Objectives  
 
5 
AIM AND OBJECTIVES 
Aim of the study:  
 To evaluate and compare the physical properties and 
biocompatibility of zinc oxide -ozonated eugenol and  that  of 
conventional zinc oxide eugenol.  
 
Objectives of the study:  
1.  To evaluate the physical properties such as hardness, solubil ity 
and pH of zinc oxide- ozonated eugenol and conventional zinc 
oxide eugenol.  
2.  To evaluate the biocompatibili ty of zinc oxide -ozonated eugenol 
and conventional zinc oxide eugenol.  
3.  To compare and correlate the physical properties and 
biocompatibility of zinc oxide- ozonated eugenol and 
conventional zinc oxide eugenol.  
 
Review of l iterature  
 
6 
REVIEW OF LITERATURE 
  
 Root  canal therapy depends on the integrally related t reatment  
phases: microbial control,  cleaning and shaping, and effect ive sealing 
of the root  canal system.  The success of t reatment  depends on the 
execut ion o f the final phase i.e.  sealing of the root  canal.  Endodont ic 
filling mater ials may be considered like t rue implants as they touch and 
are based in vital t issues o f the body. The main components of a root 
filling are: a so lid core mater ial and a sea ler.  ZOE sealers have a 
history o f successful use over extended per iod o f t ime. It  has both 
anaesthet ic and ant imicrobia l propert ies
1 0
.  
 
Torabinejad M (1993)
1 1
 stated that  sealers help to  prevent  leakage, 
reduce the possibilit y of residual bacter ia  from the canal to  invade the 
per iapical t issues and to  resolve per iapical lesions.  
 
McMichen FR et al (2003)
1 2
 stated that  the handling propert ies o f root 
canal sealers and it s clinical behaviour may be character ised by lab 
tests on their physical propert ies.  These include flow, so lubilit y,  
working t ime and set t ing t ime. He also stated that  these mater ials  
should possess adequate working t ime  for clinical handling and 
t reatment  procedures.   
 
ISO standards: ISO 6876: 2001
1 3
       
 Flow o f endodont ic sealer should have a diameter not  less than 
20mm.  
 Working t ime o f the sealer to  be less than 30 min  
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 Sett ing t ime o f the sealer should be greater than 30 min and 
upto72hrs.  
 Film thickness should not  be more than 50µm 
 Dimens ional change should not  to exceed 1.0 % in shr inkage or 
0.1% in expansion.  
 Solubilit y o f the sealer shall not  exceed 3% of mass fract ion.  
 Radio-opacity should be equivalent  to or not  less than 3mm of 
aluminium.  
 
Grossman  stated that  Zinc oxide eugeno l sealer have a history o f 
successful use over an extended per iod of t ime.  An ideal root  canal 
sealer should possess fo llowing propert ies 
1 4
. 
1.  It  should be tacky when mixed, to be able to  provide 
adhesion/sealing between the ca nal walls and the core obturat ing 
mater ial.  
2.  Flowabilit y in it s non-set  state to promote lut ing.  
3.  It  should be non- irr itat ing to  the per iapical t issues.  
4.  It  should possess a hermet ic sealing abilit y.  
5.  It  should be radiopaque.  
6.  It  should possess minimal set t ing shr inkage.  
7.  Should be non-staining on the dent in / tooth st ructure.  
8.  It  should be ideally bacter icidal or at  least  control the bacter ial 
growth.  
9.  Should have long working t ime.  
10.Inso luble in t issue flu ids.  
11.It  should be easy to  remove if necessary.  
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12.It  should be neither mutagenic nor carcinogenic.  
13.It  should not  provoke an immune react ion.  
 
 Grossman‟s or iginal formula for zinc oxide eugeno l based sealers 
contained ZnO, stabylit e resin,  bismuth sub carbonate,  bar ium sulphate 
and sodium borate with eugeno l as the l iquid component .  
 
Roth’s sol sealer (Roth‟s pharmacy, Chicago, inc.) is essent ially t he 
same as Grossman‟s or ig inal formulat ion with the subst itut ion o f 
bismuth sub-nit rate for bismuth sub-carbonate.  
 
Ricket’s formula  marketed as Kerr‟s pulp canal sealer ( Sybron endo/ 
Kerr,  Orange, CA) has long been accepted mater ial.  But  its use has 
been rest r icted for staining o f tooth st ructure from the silver used for 
radio-opacity.  
 
Tubliseal(Sybronendo/ Kerr) is a  two paste system contained in two 
separate tubes developed as non-staining alt ernat ive with bar ium 
sulphate for radiopac ity.  It  has the disadvantage of rapid set t ing t ime.  
 
Wach’s cement (Roth internat ional Inc.  Chicago) consists o f powder of 
ZnO, bismuth sub- iodide, bismuth sub-nit rate,  magnesium oxide and 
calcium phosphate.  It  has the advantage of smooth consistency and the 
Canada balsam make the sealer tachy
1 4
.  
 
Hauman CH et al (2003)
1 5
 reported that  there are many formulat ions 
and brands of sealer  that  have zinc oxide as pr imary ingredient ,  
differ ing only by other components added to the sealer.  Zinc oxide 
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sealers allow for t he addit ion o f other chemicals,  such as 
paraformaldehyde, rosin,  Canada balsam all o f which may enhance 
their propert ies.Endodont ic mater ials can be broadly categor ized  as 
those used to  maintain pulp vita lit y and those used  in pulp canal 
therapy for  disinfect ion o f the pulp  space ( irr igants and intra-canal 
medicament s) and root  cana l filling (solid mater ials and sealers).  
Biocompat ibilit y o f these endodont ic mater ials is  character ized  by 
many parameters such as genotoxicity,  mutagenic ity,  carcinogenicit y,  
cytotoxicity,  histocompat ibilit y or microbial effects.  Hence it  is  
impossible to  bio log ically character ize the mater ials  by a single test  
method alone and the ir  propert ies need to  be invest igated by a ser ies of 
var ious in vit ro and in vivo tests ina st ructured  approach.  
 
Candeiro et al (2012)
1 6
 reported that nowadays var ious kinds o f 
endodont ic sealers are available such as  sealers based on glass 
ionomer,  calc ium hydroxide, silicone, resin based and bioceramic 
mater ials.  
 
Lacey S (2005)
1 7
 stated that  as yet  no root  canal sealers has all t he 
ideal propert ies and most  leak with t ime, either through poor init ial 
adaptat ion to the canal walls or due to  solubilit y and dis integrat ion of 
the sealer.  They also stated that  successful obturat ion is achieved by 
the adhesion and stabilit y o f t he seale r to  the canal walls  which,  
amongst  other factors,  is affected by its  rheo logical propert ies.  They 
reported that  narrower tubes produced  increased velocit y,  which was 
significant  for all  sealers,  and reduced vo lumetr ic flow, which was  
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significant  for all sealers except  Grossman‟s sealer.  Reduct ion in  
powder: liquid rat io  o f Grossman‟s significant ly increased flow in 
narrow tubes and at  higher st rain rate.  
 
Eugenol (4- acyl-2-methoxy pheno l) is  an extract  of clove o il widely 
used in dent ist ry as a  therapeut ic agent ,  most  commonly as a  
component  o f zinc oxide eugeno l cement  applied as a  ba se or 
temporary dressing to  dent ine,  or as a root canal sealer
1 0
.  
 
Lindquist et al (1981)
1 8
 reported that  eugeno l that  leaches out  of zinc 
oxide eugeno l based root  canal sealers,  may part icipate in the 
development  o f per iapical inflammat ion or the cont inua t ion of a pre-
exist ing per iapical lesion.They conducted a study to check the amount  
of eugeno l released from four different  dental mater ials immersed in  
phosphate buffer measured by gas liquid chromatography.  Maximal 
release o f eugeno l from zinc oxide -eugenol cement  (ZOE) and IRM was 
attained within 5hrs and corresponded to 5% and 4%, respect ively,  o f  
the total amount  of eugeno l in each mater ial.  Eugeno l applied to 
growing cultures o f human diplo id fibroblasts reduced the number o f 
cells recovered to  a value which was 4% of t hat  found for control 
cultures which grew to form mono layers.  Confluent  mono lay ers o f H-
Uridine labeled cellcultures which were incubated for 1hr in t he 
presence o f 4 mm eugeno l lo st  approximately 100% of t his cytoplasmic 
label,  indicat ing total cell death.  
 
Branstetter J (1982)
1 9
 stated that  endodont ic sealers are used in the 
obturat ion o f root  canal system to achieve a fluid t ight  or hermet ic sea l 
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throughout  the canal including the apical foramen and canal 
irregular it ies.  
 
Bedoukian (1986)
2 0
 reported that  eugenol was first  iso lated in 1929 
and commercia l product ion commenced in the United States in the 
1940s. Eugeno l can be produced synthet ically,  t he most  pract ica l 
method being the allylat ion o f guaiaco l with allyl chlor ide.  However,  
eugeno l is  predominant ly prepared from natural o il sources by mixing 
the essent ial o il with an exces s o f aqueous sodium (3%) or potassium 
hydroxide so lut ion and shaking, leading to  the format ion of a pheno lic 
alkali salt .  The inso luble non-pheno lic port ion is then extracted with a 
so lvent  or via steam dist illat ion. The un-  disso lved port ion is removed, 
the alkali so lut ion is acidified at  low temperatures and the liberated 
eugeno l pur ified by fract ional dist illat ion.  
 
Thompson et al (1990)
2 1
 stated that  the eugeno l induced cytotoxicity 
is  influenced by the format ion o f glutathione conjugates dur ing 
oxidat ion o f eugeno l by microsomal fract ion of rat  liver and lung.  
 
Jeng et al (1994)
2 2
 invest igated the effect  of eugeno l on mouse 
fibroblast  at  with a concentrat ion higher than 3 mmol/L, and reported 
that  eugeno l was cytotoxic to  oral mucosal fibroblasts in a 
concentrat ion and t ime-dependent  manner.  They reported that  cell 
death was associated with intracellu lar deplet ion o f glutathione. Most 
of the glutathione was depleted pr ior to the onset  of cell death.  At  
concentrat ions o f 3  mmol/L and 4 mmol/L, eugeno l dep leted about  45% 
and 77% of the cells aft er one-hour incubat ion. In addit ion, eugeno l 
Review of l iterature  
 
12 
decreased cellular ATP (Adenosine  tr i-phosphate) level in a 
concentrat ion and t ime dependent  manner and they concluded that  
eugeno l is cytotoxic to oral mucosal fibroblast s.  
 
Tai et al (2002)
2 3
 stated that  zinc oxide eugeno l based sealers irr itated 
per iapical t issues invivo and exhibit ed cytotoxic effects exvivo. In this 
study, tet razolium bromide reduct ion assay, DNA precipit at ion assay,  
and DNA fragmentat ion analys is were  performed to invest igate the 
cytotoxic and genotoxic effects o f four different  root  canal sealers on 
cultured V79 cells.  These findings suggest  that  root  canal sealers 
containing formaldehyde and bispheno l-A dig lyether proved as not 
only cytotoxic but  also genotoxic.  They also stated that  mammalian test  
system might  be used rout inely for evaluat ion o f the genotoxicity o f 
dental mater ials in future invest igat ions.  
 
Ito et al (2006)
2 4
 invest igated the ant i-oxidant  act ivity o f eugeno l and 
it s isomer isoeugeno l using iron-mediated lipid peroxidat ion and auto -
oxidat ion o f Fe 2+. The inhibitory effect  of eugeno l on lipid 
peroxidat ion was less potent  with an IC 50 value o f ≈80 μm, which was 
eight -fo ld the value o f isoeugeno l.  The  mechanism o f act ion o f the two 
compounds was invest igated and it  was suggested that  the ant i-oxidant  
capacity o f eugeno l could be expla ined by the format ion of complexes 
with reduced metals.  The potent  inhibitory effect  of isoeugeno l on lipid 
peroxidat ion may be related to  the decr eased format ion o f the per -
ferryl ion or iron-oxygen chelate complex as the init iat ing factor of 
lipid peroxidat ion.  
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van Zyl et al (2006)
2 5
 conducted a study in which twenty essent ial o il 
const ituents were evaluated for their  ant imalar ial act ivity against  the 
chloroquine-resistant  st rain P.falciparum  (FCR-3).  Eugeno l exhibited 
some act ivity with an IC 50  value o f 753 μm which was lower than for  
other const ituents such as nero lido l,  lina lylacetae,  α -pinene and 
pulegone (IC 50 values ranging from 0.9 to  1.4 μ m) 
 
Singh et al(2007)
2 6
 invest igated the ant ibacter ial effect  of eugeno l on 
the growth of Gram-posit ive  (B.cereus; B.subtilis; S.aureus ) and Gram-
negat ive (E.coli; S.typhi; P.aeruginosa) bacter ia using the agar well 
diffusion method.  At  1,000 ppm,  eugenol inhibit ed the growth o f the 
bacter ia and complete inhibit ion was obtained against  P.aeruginosa  at  
a high concentrat ion o f 2,000 ppm. This inhibit ion was high in  
compar ison to ampicillin (1 mg/mL) when used as a posit ive control.  
 
Tragoolpua et al (2007)
2 7
 tested the in vit ro ant iviral act ivity o f 
eugeno l against  the herpes simplex-1: HSV-1 and HSV-2 viruses.  The 
replicat ion o f these viruses was inhibit ed with IC 50  values o f 25.6 
μg/mL  and 16.2 μg/mL  against  HSV-1 and HSV-2, respect ively.  
Addit ional invest igat ions revealed synergist ic  interact ions with a 
combinat ion o f eugeno l and acyc lovir,  a  known ant iviral drug. Studies 
have shown that  applicat ion o f eugeno l delayed the development  of 
herpes virus- induced kerat it is in a mouse model.  Eugeno l was 
evaluated for  its  ant i-HSV propert ies on standard  HSV-1(F),  standard 
HSV-2(G) and ten HSV iso lates using the plaque reduct ion assay. Only 
HSV-1 iso lates 1 and 30 were inhibited by eugeno l and the inhibit ion 
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against  these iso lates was greater than for  the extract  obtained from the 
flower buds o f E. caryophyllata.  
 
Barceloux et al (2008)
2 8  
reported that  Clove has been used in ancient  
China as a spice and fragrance for more than 2,000 years.  Medic inally,  
the well-known t radit ional remedy o f applying clove o il to  t reat  a 
toothache was documented for the first  t ime in 1640 in „Pract ice o f 
Phys ic‟ in France. In Chinese t radit ional medicine clove o il has been 
used as carminat ive,  ant ispasmodic,  ant ibacter ial and ant  parasit ic  
agent ,  while t he buds were used to  t reat  dyspepsia,  acute/chronic 
gastr it is and diarrhoea.  
 
Daniel et al (2009)
2 9
 invest igated about  Eugenia caryophyllata,  which 
contains eugeno l and acetyleugeno l as major const ituents for potent ial 
ant i- inflammatory act ion on COX-2 (cyclooxygenase)  and LOX 
enzymes. The o il exhibited st rong inhibitory act ivity against  COX -2 
(58.15%) and 15-LOX (86.15%) enzymes at  10μg/mL and 25μg/mL, 
respect ively.  The ant i- inflammatory act ivity o f eugeno l was evaluated  
by inflammatory exudate vo lume and leukocyte  migrat ion in  
carrageenan- induced pleur isy and carrageenan- induced paw oedema 
tests in rats.  Eugeno l (200 and 400 mg/kg) was found to  reduce the 
vo lume o f pleural exudates without  changing the total blood leukocyte 
count  indicat ing the ant i- inflammatory potent ial o f eugeno l.  
 
Okamoto et al (2009)
3 0
 evaluated the anaesthet ic property o f eugeno l 
in juvenile Lepor inusmacrocephalus,  a fish species also known as 
“piavuçu”. Eugeno l had st rong anaesthet ic effect  on L. macrocephalus 
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and a dose o f 37.5 mg/L o f eugeno l was recommended for the fast  and 
safe anaesthesia o f piavuçu juveniles (n = 72).  In a similar  
invest igat ion,  t he efficacy o f benzocaine  and eugeno l as anaesthet ics in  
Trachinotusmarginatus juvenile fish was studied. Benzocaine and 
eugeno l,  at  50 ppm, induced fast  anaesthesia and recovery (3 min and 5 
min, respect ively).  In European sea bass (Dicentrarchuslabrax) (n = 
240),  eugeno l induced deep anaesthesia without  substant ially affect ing 
their blood profile  as measured  by serum cort iso l,  g lucose and 
haematocr it  va lues.  Induct ion was rapid but  recovery was very slow 
even at  low concentrat ions.  
 
Hussain et al (2011)
3 1
 tested eugeno l alone and in combinat ion with a 
chemotherapeut ic drug (gemcitabine) to  evaluate it s inhibit ory effect  
against  cancer cells.  Eugeno l showed dose-dependent  select ive 
cytotoxicity towards HeLa cells in compar ison to  normal cells.  
Furthermore, eugeno l and gemcit abine in  combinat ion induced growth 
inhibit ion and apoptosis (programmed cell death)  at  lower  
concentrat ions in compar ison to  the individual compounds indicat ing  
synergist ic int eract ions.  Eugeno l (150 μm) and gemcitabine (15 μm) 
resulted in a decrease in cell viabilit y from 84% (eugeno l a lone) and 
51% (gemcit abine  alone) to  47% in combinat ion. Treatment  o f co lon 
cancer cells with eugeno l resu lted in the reduct ion o f int racellular non -
protein thio ls and an increase in the ear lier lipid layer break. In 
addit ion, dissipat ion o f mitochondr ial membrane potent ial and 
generat ion of react ive oxygen species accompanied the eugeno l -
induced apoptosis.  
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Marcos-Arias et al (2011)
3 2
 evaluated the effect  o f eugeno l against  38 
Candida species iso lated from denture -wearers and 10 co llect ion 
Candida st rains using the CLSI M27-A3 broth micro dilut ion method. 
It  was found that  eugeno l exhibit ed ant ifungal act ivity with the MIC 
value ranging from 0.06 to  0.25% (v/v),  while t he minimum 
concentrat ion o f drug that  inhibit ed 50% of the iso lates tested (defined 
as MIC 50 ) ranged from 0.06 to  0.12% (v/v) .  MIC and skin lesion 
scor ing tests were performed in vivo to  evaluate the ant ifungal effect  
of eugeno l in a guinea pig model infected by Microsporum gypseum.  
Eugeno l exhibit ed promising act ivit y with the MIC value ranging from 
0.01 to  0.03%. The sk in lesion scor ing test  showed that  eugeno l was 
clinically effect ive at  improving the lesion dur ing the first  week o f 
applicat ion. However,  eugeno l did not improve the skin lesions 
infected by M. gypseum  as determined in the hair culture test .  
 
 The word ozone (O3)  is  der ived from the Greek word ozein 
(odorant).  It  is one o f t he most  powerful ant imicrobia l agents available 
for use in medicine and dent ist ry.  In 1920, Dr.Edwin Parr,  a Swiss 
dent ist  started the use of O 3  as a part  of his disinfect ion system
3 3
.  
 
Mudd JB et al (1969 )
3 4  
conducted a study on the react ion of ozone 
with amino acids and proteins and stated that  ozone acts on bacter ial 
cell membranes by oxidat ion o f their lipid and lipoprotein component .  
 
Roy D et al (1981)
3 5  
conducted a study on the mechanism o f 
enteroviral inact ivat ion with ozone by compar ing the sedimentat ion 
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profiles o f nucleic acids o f ozone-exposed viruses with those o f control 
viruses,  they observed that  viral nucle ic acid was damaged as a result  
of ozonat ion. It  would appear that  the major cause o f viral inact ivat ion,  
as determined with po liovirus 1,  by ozone using a residual 
concentrat ion less than 0.3 mg/liter and a contact  t ime up to  2 min is 
damage o f the RNA.  They concluded that  all viruses are suscept ible to 
ozone; yet  differ widely in their suscept ibilit y and also stated that  the 
analys is o f viral components showed damage to the po lypept ide and 
envelope proteins impair ing viral at tachment  capabilit y.  
 
Alvarez et  al (1982)
3 6
 studied the germic idal propert ies o f the 
ozonized sunflower o il (OLEOZON),  they decided to  make an 
invest igat ion in 80 children between 1 and 14 year o ld,  with t he main 
object ive o f eva luat ing the effect iveness of the OLEOZON in pr imary 
pyoderma, compar ing this with Gentamycin cr eam. The invest igat ion 
was carr ied out  in areas o f health o f the general teaching hospital 
"Comandante Pinares ",  San Cr istoba l,  Pinar del Rio, last ing 6 months.  
Pat ients were randomly assigned to both group o f t reatment ; 
exper imental (using OLEOZON) and control (using Gentamycin)  .To 
all pat ients bacter io logical studies were done, at  the beginning and 
after 15 days o f t reatment .  The result s demonstrated that  the most  
frequent  iso lated germ was the Streptococcus haemolyt ic o f group A. 
Healing effect iveness aft er 15 days o f treatment ,  was 68 % for the 
OLEOZON and 28 % in those pat ients where Gentamycin was used. No 
side effects were observed.  
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Morgolis HL et al (1985)
3 7
 reported that  ozone had a severely 
disrupt ive effect  on car iogenic bacter ia,  result ing in eliminat ion o f 
acidogenic bacter ia.  The st rongest  naturally occurr ing ac id,  produced 
by acidogenic bacter ia,  pyruvic acid is decarboxylated to  acet ic acid,  
which in turn encourages remineralisat ion.  
 
Arsalane K et al (1995)
3 8  
conducted a study on ozone st imulat ion o f 
inflammatory med iators and reported that  ozone behaves as a  weak 
cytokine such as tumour necrosis factor (TNF-α),  inter leukin (IL-2,  IL-
6) and t ransforming growth factor -beta (TGF-β).  In t he present  study,  
the in vit ro effect  of low concentrat ions of O3  (0.1 to  1 ppm) was 
evaluated on cell viabilit y and cytokine secret ion by alveo lar  
macrophages (AM) from guinea pigs and healthy subjects.  Cell injury 
was est imated immediately after O 3  exposure by evaluat ion o f ATP cell 
content  as measured by bio luminescence and lact ic dehydrogenase 
(LDH) release in the culture medium.   
 
Mudd JB et al (1997)
3 9
 invest igated the effect  of ozone on blood cells  
and concluded that  ozone reduces or eliminates clumping o f red blood 
cells and it s flexibilit y is  restored along with oxygen carrying abilit y.  
Ozone was applied to  sealed red cell ghost  membranes at  the rate  of 95 
mmol/min for per iods up to 20 min. Acetylcho line esterase,  on the 
outer face o f the membrane, was inhibited up to  20%. Glyceraldehyde -
3-phosphate dehydrogenase,  on the inner surface o f the membrane, was 
inhibited up to  87%. These differences reflect ed the inherent  
suscept ibilit ies o f t he two enzymes and the presence or absence o f the 
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membrane barr ier.  They also stated that  there was no decline in the 
amount  of cho lestero l in the lip ids der ived from ozone -t reated red cell 
membranes.  
 
Liu Z et al (1998)
4 0
 stated that  the applicat ion o f ozonized o ils o f 
vegetal source const itutes an appropr iate method for the local t herapy 
of several diseases.  The interact ion o f ozone with these o ils produces a 
mixture o f chemical compounds namely ozonoides and peroxides  with 
bet ter germicidal power.  The result s o f topical applicat ion of ozonized 
oil (OLEOZON) in dermatological diseases o f viral,  fungi and bacter ial 
origin,  dur ing 9 years o f study, were presented. Among the diseases o f 
bacter ial or igin (pyoderma),  600 pat ients were t reated, obtaining 
healing cr iter ion in 87%. In case o fmycot ic diseases 
(epidermophythosis and onychomycosis),  1000 pat ients received the 
t reatment ,  with 91% of healing. In viral diseases (herpes simplex),  300 
pat ients were t reated and in 74% the relapses disappeared. No side 
effects were observed in any o f the cases after t reatment .  
 
Oizumi M et al (1998)
4 1
 reported that  oral microorganisms and no 
viable C.a lbicans were detected after exposure to  flowing ozonated  
water (2 or 4 mg/L) for 1 min, suggest ing the  applicat ion o f ozonated  
water might  be useful in reducing the number  o f C.albicans on denture 
bases.  
Velano HE et al (2001)
4 2  
conducted invit ro studies and reported that 
ozone was effect ive over most  of the ba cter ia found in cases of pulp 
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necrosis.  Ozone is effect ive when it  is used in suffic ient  concentrat ion,  
for an adequate t ime and delivered appropr iately.  
 
Ebensberger U et al (2002)
4 3
exper imented the use o f ozonated water 
in decontaminat ion o f avulsed toot h befo re replantat ion and concluded 
that  2 minute irr igat ion o f avulsed teeth with non- isotonic ozonated 
water not  only provides mechanical cleansing but  also decontaminated 
the root  surface with no negat ive effect  on per iodontal cells.  
 
Reth et al (2002)
4 4
 reported that  ozone reacts with unsaturated fat ty 
acids of the lipid layer in cellu lar membranes,  forming hydrogen 
peroxide, one o f the most  significant  cytokine inducers.  It  also plays an 
important  role as a secondary messenger in the init iat ion and 
amplificat ion of signaling at  the ant igen receptor.  The ant igen 
receptors themselves are H 2O2-generat ing enzymes and that  the 
oxidat ive burst  in macrophages seems to play a ro le not  only in  
pathogen killing but  also in the act ivat ion of these cells as well as  
neighbor ing cells.  
 
Holmes J (2003)
4 5
 studied the c linical reversal o f root  car ies by ozone 
using double blinded randomized control study and reported that  ozone 
is capable o f clinically reversing the leathery root  carious lesion. He 
assessed the effect  o f an ozone delivery system, combined with the 
daily use of a re-mineralizing pat ient  kit , on the clinical sever it y o f 
non-cavit ated leathery pr imary root  carious lesions (PRCL’s) ,  in an 
older populat ion group. He also reported that  leathery non -cavit ated 
pr imary root  car ies can be arrested non-operat ively with ozone and re -
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mineralizing products and this t reatment  regime is an effect ive 
alternat ive to convent iona l “dr illing and filling”.  
 
Walker JT et al (2003)
4 6
 reported that  in model dental unit  water 
lines,  ozone achieved a 57% reduct ion in  bio film and a 65% reduct ion 
in viable bacter ia in spite o f being used in a very low dose and with a 
short  t ime o f applicat ion. They also concluded that  dental 
manufacturers should be invited to  design dental units that  incorporate 
automated devices to  disinfect  DUWLs.  
 
Nagayoshi M et al (2004)
47
 reported that ozonated water had strong 
bactericidal act ivity against bacteria in plaque biofilm. It was found that 
ozonated water (0.5–4mg/L) was highly effect ive in killing of both gram-
posit ive and gram-negat ive microorganisms. Gram-negat ive bacteria, such 
as P.gingivalis P.endodontalis were more sensit ive to ozonated water 
than gram-posit ive oral st reptococci and C .albicans in pure culture.  
 
Baysan A et al (2004)
4 8  
conducted a study on the efficacy o f ozone on 
pr imary root  car ies lesion (PRCL) and found that  ozone applicat ion for 
eit her for  10 or 20 s dramat ically reduced most  o f t he microorganisms 
in PRCLs without  any side effects recorded at  recall int ervals between 
3 and 5.5 months.  
 
Young SB et al (2004)
4 9
 examined the mechanism o f killing B.subti lus  
spores by ozone and reported that  it  seems to render the spores 
defect ive in germinat ion perhaps because o f damage to the s pore‟s 
inner membrane.  
Review of l iterature  
 
22 
Huth KC et al (2005)
5 0
 conducted in vit ro studies with short  term 
fo llow-up and assessed the effect  of ozone on pit  and fissure car ies and 
pr imary root  caries with result s showing significant  reduct ions in t he 
number of microorganisms in t he car ious lesions.  In this study gaseous 
ozone (HealOzone) was applied once for  40 seconds to the randomly 
assigned test  molar o f each pair  without  the use o f re-mineralizing  
so lut ions.  Lesion progression or reversal was monitored by the laser  
fluorescence system DIAGNOdent  for up to  3 months and the 
deter iorat ion or improvement  compared between the ozone -t reated 
lesions and the untreated control lesions   
  
Celiberti  P et al (2006)
5 1
 stated that  ozone had no influence on the 
phys ical propert ies o f the enamel to  enhance or hinder the sealing 
abilit y.  Thus, ozone can be applied over intact  and prepared enamel 
dur ing the restorat ion process.  They also  stated that  the applicat ion o f 
gasiform ozone does not  affect  the modulus o f elast icit y and the 
Vicker‟s hardness o f dent in.   
 
Polydorou OPK et al (2006)
5 2  
exper imented the ant imicrobial efficacy 
of ozone and reported that  long exposure to  ozone gas has a st rong 
ant i-bacter icidal effect  on microorganisms within the dent inal tubules 
of deep cavit ies,  which could result  in increasing the clinical success 
of the restorat ion. In this study thirty- five human molars were divided 
into 5 groups. Cavit ies were then cut  into the teeth (n=28 cavit ies pe r  
group).  After ster ilizat ion, the teeth were left  in broth cultures o f 106 
co lony-forming unit s (CFU) ml) o f S.  mutans at  36ºC for 48hrs.  The 
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appropr iate t reatment  fo llowed (group A, control; group B, Clearfil SE 
Bond; group C, Clearfil Protect Bond; grou p D, 40 s of t reatment  with 
ozone; and group E, 80 s o f t reatment  with ozone),  and the cavit ies 
were then filled with composite resin.  After 72hrs,  the restorat ions 
were removed, dent in chips were co llected with an excavator,  and the 
total number o f microo rganisms was determined. All t reatments 
significant ly reduced the number  o f S.mutans present  compared with 
the control group. The ant imicrobia l effect  of both bonding systems 
and t reatment  with 80 s o f ozone was significant ly higher t han the 40 s 
ozone t reatment .  They concluded that  Heal  Ozone and the bonding 
systems showed st r iking ant imicrobial effects against  S.mutans.  
 
Baysan A et al (2007)
5 3
 assessed the effect  of the ozone-mediated 
killing o f bacter ia in infected dent ine associated with non -cavitated 
occlusal car ious lesions and stated that  the longer the contact  t ime, the 
bet ter the microbio logical kill  rate.  It  was reported that  by increasing  
the contact  t ime from 10 to  20 s,  the bacter ial kill rate changed from 
ozone being a disinfectant  to acquir ing ster ilizing effect .  
 
BaysanA et al (2007)
5 4
 suggested that  the reversal o f car ious lesions 
after t reatment  with ozone depend on the size and localizat ion o f the 
car ious lesion. Non-cavit ated lesions were more likely to  reverse than 
cavitated lesions.  The hardness values improved significant ly in the 
ozone-t reated test  lesions aft er 4,  6,  and 8 months (P <0.05) compared 
with baseline while t he control lesions had no significant  change in  
hardness at  any recall int erval.  
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Huth KC et al (2007)
5 5
 stated that  Ozonated water has an excellent  
ant i-  inflammatory capacity on NF (nuclear factor) -kappa system, a 
paradigm for inflammat ion-associated signalling/t ranscr ipt ion. Their  
result s showed that  NF-kappaB act ivity in oral cells  in per iodontal 
ligament  t issue from root  surfaces o f per iodontaly damaged teeth was 
inhibited fo llowing incubat ion with ozonized medium.  
 
Muller et al(2007)
5 6
compared the influence o f ozone gas with 
photodynamic therapy (PDT) and known ant isept ic agents (2% 
Chlorhexid ine,  0,5 and 5% hypochlor ite  solut ions) on a mult ispecies 
oral bio film in vit ro.  The fo llowing  bacter ia were studied –  
A.naeslundii,  F.nucleatum, S.sobrinus,  S.oralis and C.albicans .  
Gasiform ozone was produced by vacuum ozone deliver y system Kavo  
Heal ozone.  They concluded that  the matr ix-embedded microbial 
populat ions in bio film are  well protected towards ant imicrobia l agents.  
Only 5 % hypochlor ite so lut ion was  able to  eliminate all bacter ia  
effect ively.  Usage o f gasiform ozone or PDT was notable to  reduce 
significant ly or completely eliminate bacter ia in the bio film.  
 
Petrucci MT et al (2007)
5 7
 conducted a study in which they compared 
the use o f ozonated oil in an exper imental group to a control group in 
which ant ibiot ic t herapy was used in the t reatment  o f alveo lit is ,  it  was 
found that  pat ients t reated with  ozonated o il healed  more quickly.  
There was complete healing o f t he lesions with the disappearance o f 
symptoms.  
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Nogales CG et al (2008)
5 8
 conducted an exper imental study on  
Ozonated o il and concluded that  when applied on herpes labia lis  and 
mandibular osteomyelit is demonstrated faster healing t imes than 
convent ional protocols.  Ozone in these cases neutralises  herpes vir ions 
by direct  act ion, thus inhibit ing bacter icidal supra - infect ions and 
st imulat ing the healing o f t issues through circulatory prompt ing.  
 
Noguchi et al (2009)
5 9
 reported that  irr igat ion o f the root  surface o f 
avulsed teeth with ozonated water did not  reveal a negat ive effect  on 
per iodontal ligament  cell pro liferat ion. In this study aft er the pre -
t reatment  of LPS ( Lipopolysacchar ide)  with aqueous ozone, effects o f 
LPS and aqueous ozone -t reated LPS on cell viabilit y; calc ificat ion 
abilit y; expression o f cyc looxygenase 2 (COX-2),  inter leukin 6 (IL-6),  
and tumour necrosis factor α (TNF -α) ; and act ivat ion of p38 o f KN -3  
cells were examined. Their results suggest  that  odontoblast ic cells 
exhibit  inflammatory responses against  LPS and that  ozonated wa ter 
has the abilit y to  improve LPS- induced inflammatory responses and 
suppression o f odontoblast ic propert ies of KN -3 cells through direct  
inhibit ion o f LPS.  
 
Huth KC et al (2009)
6 0
demonstratedant imicrobia l act ion against  
bacter ial st rains,  such as Mycobacteria,  E.faecalis,  and C.albicans.  
Notably,  when the specimen was irr igated with sonicat ion, ozonated 
water had near ly the same ant imicrobia l act ivity as 2.5% NaOCl. This 
study invest igated whether gaseous ozone (4 ·  106 l gm.) and aqueous 
ozone (1.25–20 l gm.) exert  any cytotoxic effects on human oral 
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epithelia l cells  and gingival fibroblast  (HGF-1) cells compared with 
established ant isept ics [chlorhexidine  digluconate (CHX) 2%,  0.2%; 
sodium hypochlor ite  (NaOCl) 5.25%, 2.25%; hydrogen  peroxide (H2O2) 
3%), over a t ime of 1 min, and compared with the ant ibiot ic,  
metronidazo le,  over 24hrs.  Cell counts,  metabo lic act ivity,  Sp -1 
bind ing, act in levels,  and apoptosis were evaluated. Ozo ne gas was 
found to have toxic effects on both cell  types.  Essent ially no cytotoxic 
signs were observed for aqueous ozone suggest ing it s biocompat ibilit y 
when compared to  other chemica ls.  
 
Kim HS et al (2009)
6 1
 has undertaken a study to evaluate the 
therapeut ic effects o f topical ozonated olive o il on acute cutaneous 
wound hea ling in a guinea pig model and also to  elucidate its  
therapeut ic mechanism. Aft er creat ing full -thickness skin wounds on 
the backs o f guinea pigs by using a 6 mm punch biopsy, we examined 
the wound healing effect  of topically applied ozonated olive o il (ozone 
group),  as compared to  the pure o live o il (oil group) and non -treatment  
(control group).  Immunohistochemical staining demonstrated up 
regulat ion o f platelet  der ived growth factor (PDGF), t ransforming 
growth factor-beta (TGF beta) and vascular endothelial growth factor 
(VEGF) expressions,  but  not  fibroblast  growth factor expression in t he 
ozone group on day 7,  as compared with the o il gro up. He concluded 
that  these results demonstrate that  topical applicat ion o f ozonated o live 
oil can acce lerate acute cutaneous wound repa ir  in a guinea pig in  
associat ion with the increased expression of PDGF, TGF -beta,  and 
VEGF.   
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Atabek et al (2011)
6 2
 conducted a study to evaluate the efficiency o f 
ozone alone and with a re-mineralizing solut ion fo llowing applicat ion 
on init ia l pit  and fissure car ies lesions in permanent  mandibu lar  
molars.  In their study forty children (9 -12 years) having non-cavit ated 
fissure car ies lesions on bilateral 40 first  permanent  mandibular molar  
teeth were part ic ipated in the study. Pat ients were randomly allocated 
to  2 exper imental groups consist ing of 20 subjects.  In the first  group, 
ozone was applied once for 40 seconds to  the  assigned test  teeth o f 
each pair.  In the second group, ozone was applied once for 40 seconds 
to  the assigned test  teeth o f each pair  with the use o f re -mineraliz ing 
so lut ion. Progression or improvement  of the car ies was assessed at 
base line,  immediately a ft er t reatment  and at  1-,2-,3-,  and 6 month 
fo llow-up by compar ing the DIAGNOdent  va lues,  Clinical Sever it y 
Indexes,  Oral Hygiene Scores.  They concluded that  ozone t reatment  
eit her alone or combined with a re -mineraliz ing so lut ion was found to 
be effect ive for remineralisat ion o f init ial fissure car ies lesions.  
 
Gerspach et al (2012)
6 3
 invest igated the ant imicrobia l efficacy o f 
gaseous ozone on bacter ia adhered to  var ious t itanium and zirconia 
surfaces and to  evaluate adhesion o f osteoblast  like MG-63 cells 
to  ozone-t reated surfaces.  Saliva-coated t itanium (SLA and po lished)  
and zirconia (acid etched and po lished) disks served as substrates for 
the adherence of S.sanguinis and P.gingivalis .  The test  specimens were 
t reated with gaseous ozone (140 ppm; 33 mL/s) for 6 and 24 s.  Bacter ia 
were re-suspended using ult rasonicat ion, ser ially diluted and cultured. 
MG-63 cell adhesion was analysed with reference to  cell at tachment ,  
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morpho logy, spreading, and pro liferat ion. Surface topography as well 
as cell morpho logy o f the test  specimens was inspected by SEM.  They 
concluded that  gaseous ozone showed select ive efficacy to  reduce 
adherent  bacter ia  on t itanium and zirconia without  affect ing adhesion 
and pro liferat ion of osteoblast ic cells.  This in vit ro s tudy may provide 
a so lid  basis for clinical studies on gaseous  ozone t reatment  of per i-
implant it is and revealed an essent ial base for suffic ient  t issue 
regenerat ion.  
  
Chandra SP et al (2014)
6 4  
conducted a study to evaluate the success 
rate of mixture o f ozonated o il and zinc oxide as a  pr imary teeth root 
filling mater ial.  The study inc luded 60 infected pr imar y mandibu lar  
molars which were equally divided into study group (ozonated o il -zinc 
oxide) and control group (zinc oxide -eugeno l).  Pulpectomy procedure 
was performed and the children were fo llowed at  regular intervals.  All 
the children were available for eva luat ion at  the end o f 12 months.  The 
teeth were evaluated for success or failure based on clinical and 
radiographic cr iter ia by a blinded invest igator.  Clinical and 
radiographic evaluat ion suggested that  teeth obturated with ozonated 
oil-zinc oxide demonstrated good success rate (93.3 %) as compared to 
zinc oxide eugeno l (63.3 %). However ,  no stat ist ically significant  
var iat ion (p = 0.408) was observed between the groups. They 
concluded that  Ozonated o il-ZnO demonstrated a good clinical and 
radiographic success at  12 months fo llow -up and it  can be considered 
as an alt ernat ive obturat ing mater ial in infected pr imary teeth.  
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Noites et al (2014)
6 5
 conducted a study to determine whether irr igat ion 
with sodium hypochlor ite,  chlorhexidine,  and ozone gas,  alone or in 
combinat ion, were effect ive against  E.faecalis and C.albicans  and 
concluded that  only the combined act ion of 2% CHX and ozone gas for 
short  period promotes the complete eliminat ion o f both microorganisms 
tested in the tooth model.  The result s of this study could lead to 
redirect  efforts towards new protocols for reducing microbial load in  
infected root  canals looking for  synergisms between new moda lit ies 
(ozone) or already known ant imicrobial products.  
 
Anand et al (2015)
6 6
evaluated the ant ibacter ial property o f ozonated 
water,  whit e wine (14%) and de-alcoho lised white wine against  
S.mutans  and E.faecalis  and concluded that  ozonated  water has the best 
ant ibacter ial property among the study groups and the ant ibacter ia l 
act ion o f Calcium hydroxide is enhanced when it  is  mixed with de -
alcoho lised white wine.  
 
Ahmedi  et al (2016)
6 7
assessed the efficacy o f ozone gas (O 3) on the 
reduct ion o f dry socket  (DS) occurrence fo llowing surgical extract ion 
of lower jaw third molars and concluded that  O 3  gas has a posit ive 
effect  on reducing the development  of DS and pain fo llowing third 
molar  surgery. The microbio logical and metabo lic capabilit ies o f 
O3  for promot ing haemostasis,  increasing the supply o f oxygen, and 
inhibit ing bacter ial pro liferat ion increase the opportunit ies for its use 
in all fields o f surgery.  These changes on the cellular  level  exp lain 
elevat ion o f funct ional act ivity and regene rat ion potent ial of t issues 
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and organs which may account  for the increased percentage of viabilit y 
in mouse fibroblasts when t reated with ozonated eugeno l.  It  also 
act ivates aerobic processes like glyco lys is and Krebs cycle at  cellular  
level to st imulate blood circulat ion; hence ozone is also used for 
t reatment  of circulatory disorders.  
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MATERIALS AND METHODS 
Materials used  
1.  Zinc oxide powder (Dental Products o f India,  Mumbai).  Batch 
no: LC 01  
2.  Eugeno l (Dental Products of India,  Mumbai).  Batch no: LG 01 
3.  Stainless steel r ings (dimensions : height - 1.5 mm; inner 
diameter- 10mm) 
4.  Glass slab.  
5.  Stainless steel spatula.  
6.  Ozonator machine (Eltech Ozonators,  Mumbai).  Model no:D-400 
7.  Humidity chamber (calibrated  Labtherm Humidity chamber).  
8.  Mett ler  AE 260 Delta range Analyt ical Balance (Mett le r-  Toledo 
Internet  INC, Columbus OH).  
9.  Shore A Hardness Durometer.  
10.pH meter (  Eutech Instrument ,  pH tester).  
11.Petri dish.  
12.Fibroblast  culture medium.  
13.MTT reagent  
14.Spectrophotometer  
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Methods 
 This study was conducted to  evaluate the phys ical propert ies and 
biocompat ibilit y o f z inc oxide –  ozonated eugeno l and convent ional 
zinc oxide eugeno l as an endodont ic sealer.  Invit ro lab test ing was 
conducted to  evaluate  and compare the hardness,  so lubilit y,  pH and 
biocompat ibilit y o f zinc oxide-ozonated eugeno l and convent ional zinc 
oxide-eugeno l.  
 
 Eugeno l was ozonated using ozonator machine with an output  of 
400mg/hr.  100ml o f eugeno l is  taken in a glass beaker and subjected to 
ozonat ion for a t ime per iod of 30 min.  
 
 Zinc oxide powder and eugeno l were weighed be fore 
manipulat ion us ing Mett ler analyt ical balance with an accuracy o f 
0.0001g. Pre-weighed quant it ies o f zinc oxide powder was mixed with 
ozonated and convent ional eugeno l in t he rat io  6:1 by weight  ( P:l 
ratio).  Manipulat ion was done as per manufacturer’s  inst ruct ions and 
fo llowing physical propert ies were evaluated. Samples were d ivided 
into two groups Zinc oxide-eugeno l (Group-I) and Zinc oxide-ozonated 
eugeno l (Group-II). 
 
Hardness of the mixed samples  was measured using Shore hardness 
Durometer type A (ADIS Gauges and Tools Manufactur ing Company, 
Mumbai) with an intender t ip Hardened steel rod 1.1 mm –  1.4 mm 
diameter,  with a t runcated 35° cone, 0.79 mm diameter.  The samples 
were mixed and 10 stainless steel r ing molds o f inner diameter 10mm 
and height  1.5mm were used to  shape the samples.  After predetermined 
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per iods o f 12hrs and 24hrs the hardness of the sealer samples were 
measured using Shore hardness Durometer t ype A. The load applied 
was 0.822 Kg with a result ing force of 8.064 N.  
 
pH change of the samples  was measured using a previously calibrated 
digit al pH meter (Eutech Instrument ,  pH tester).  The samples mixed 
immediately after manipulat ion were denoted as fresh samples,  and the 
samples mixed and stored in the incubator ( 37°C, >95% relat ive 
humid ity) for a per iod o f 12hrs and 24hrs were denoted as set  samples.  
Stainless steel r ings of inner diameter 10mm and height  1.5mm were 
used to  shape the molds.  Each set  sample was put  in a flask containing 
10ml o f dist illed water and stored at  37°C througho ut  the study per iod.  
For fresh samples,  the same vo lume as the set  samples o f mixed sealer  
was placed in a flat  bottom container containing 10ml o f dist illed water 
at  37°C. After predetermined per iods o f 12, 24 and 48hrs the pH o f t he 
so lut ion was measured using a calibrated digit al pH meter.  
 
Solubi lity was tested as a percentage o f the mass o f specimen removed 
from the dist illed water compared with the or iginal mass o f the 
spec imens. Three 1.5 mm thick stainless steel r ing o f inner diameter 
10mm were used for  each group. The r ings were filled with sealers and 
supported by a glass plate.  The filled molds were placed in an 
incubator (37°C, >95% relat ive humidity) for a per iod o f 24 hrs.  The 
samples were removed from the mold and weighed three t imes each 
with an accuracy o f 0.0001g (Mett ler analyt ical balance).  Each sample 
was put  in a petr i dish,  which was weighed before use with 50ml 
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dist illed water.  Then the samples were discarded, and the p etr i dish 
were dr ied in an oven at  110 c,  cooled in the desiccator to  room 
temperature,  and reweighed. The amount  of sealer removed from each 
spec imen was calculated as t he difference between the init ia l mass and 
final mass of the petr i dish.  
 
Biocompatibi lity  o f the tested samples was evaluated using the MTT 
(3-(4,5-dimethylthiazo l-2-yl)-2,  5-diphenyltet razo lium bromide)  
tet razolium reduct ion assay. It  was the first  homogeneous cell viabilit y 
assay developed for a  96-well format  that  was suitable for high 
throughput  screening (HTS).The MTT substrate was prepared in a 
phys io logica lly balanced so lut ion, added to cells in culture at  a final 
concentrat ion o f 0.2 - 0.5mg/ml, and incubated for 1 to  4 hours.  After 
24hrs biocompat ibilit y was evaluated as the percentage o f viabilit y o f 
mouse fibroblast  cell line L929 when test  samples were added to it . 
The quant it y o f formazan (presumably direct ly proport ional to  the 
number o f viable cells) is measured by recording changes in  
absorbance at  570 nm using a plate read in g spectrophotometer.   
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Flow chart:  
Ozonation  
Eugeno l is taken in a 100ml glass container  
 
Ozone gas is bubbled through eugeno l using ozonator machine 
400mg/hr/30mins  
 
Concentrat ion o f ozone is calculated using ozone analyzing st r ips 
(under 0.01ppm)  
 
 
Manipulation  
 
Zinc oxide (powder)  
6:1 
Convent ional eugeno l           ozonated eugeno l  
 
 
Group I   Group II  
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Hardness of the mixed sealers  was measured using Shore hardness 
Durometer type A (ADIS Gauges and Tools Manufactur ing Company, 
Mumbai)
 
pH change  o f the samples was measured using a previously calibrated 
digit al pH meter (  Eutech Instrument ,  pH tester).  
 
 3 samples for each group were subjected to  pH test ing  
  
 
 
 
 
 
Subjected to pH test ing  
 
Stainless steel r ings of inner diameter 10mm and height  1.5mm - 
shape the molds.  
 
10 samples for each group were subjected to  hardness test ing  
 
After 12hrs and 24hrs the hardness o f the sealer samples were 
measured.  
 
 
Samples mixed immediately 
Samples mixed and stored in 
the incubator (set samples) 
After 12hrs After 24hrs Fresh samples 
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Solubility was tested as a percentage o f the mass o f specimen removed 
from the dist illed water compared with the or iginal mass o f the 
spec imens.  
 
Stainless steel r ings of dimens ions 1 .5x10mm were used to   
shape the samples.  
 
3 samples for each group were subjected to  solubilit y test ing  
 
Samples were removed from the mold  
 
Weighed three t imes each with an accuracy 0.001g  
 
Each sample was put  in a petr i dish -  weighed before use  
with 50ml d ist illed water.  
 
Samples discarded from petr i dish,  
 
Dr ied in an oven at  110° C, cooled in the desiccator  
and re-weighed.  
 
Amount  of sea ler removed from each specimen  
(w1 –  w2 of the petr i dish)  
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Biocompatibi lity  o f the tested samples were evaluated using the MTT 
(3-(4,5-dimethylthiazo l-2-yl)-2,  5-diphenyltet razo lium bromide)  
tet razolium reduct ion assay.  
 
 
Mouse fibroblast  cells  (L929) and test  compounds prepared  
in 96-well plates  
 
Incubated for desired per iod of exposure.  
 
10µl MTT so lut ion added per well -  final concentrat ion  
of 0.45 mg/ml.  
 
Incubated for 1 to 4hrs at  37°C.  
 
100 µl so lubilisat ion so lut ions  added to each well to   
disso lve formazan crystals.  
 
Absorbance recorded at  570 nm to check  
the % of viabilit y.  
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Armamentarium 
Figure 1: Zinc oxide powder,  Eugeno l,  Glass slab and stainless steel 
spatula.  
 
 
     Figure 2 :Stainless steel r ing.      Figure 3:  Ozonator D-400 
       Dimension : 1.5 x 10 mm  
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Figure 4: Eugeno l ozonated by bubbling gases through it .  
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Figure 5: Shore hardness Durometer t ype A (ADIS Gauges and Tools 
Manufactur ing Company, Mumbai)  
 
 
Figure 6: Calibrated digital pH meter (Eutech Instrument ,  pH tester).  
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Figure 7: Samples shaped using stainless steel mou lds  
 
 
Figure 8: Mett ler AE 260 Delt a range Analyt ical Balance  
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   Figure 9 :  MTT Reagent       Figure 10: Micro plate reader  
           
 
           
 
     
Figure 11 :Biocompat ibilit y 
Group I  
Figure 12: Biocompat ibilit y 
Group II  
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RESULTS 
 This study was conducted to  evaluate the phys ical propert ies and 
biocompat ibilit y o f zinc oxide –  ozonated eugeno l and to  compare it  
with convent ional zinc oxide eugeno l as an endodont ic sealer.  Eugeno l 
was ozonated using ozonator machine by bubbling ozone through it .  
The powder and liquid were mixed in the rat io  o f 6:1 by weight  and the 
mixed samples were divided into two groups: Group I (zinc oxide 
eugeno l) and Group II (zinc oxide –  ozonated eugeno l).  Phys ical 
propert ies such as hardness,  pH, so lubilit y and biocompat ibilit y o f t he 
samples were evaluated and compared.  The obtained results were 
tabulated and the data co llected were stat ist ically analysed us ing 
unpaired T test  with P value significant  at  5% level (p<0.05).  
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Hardness of the mixed samples  was measured using Shore A hardness 
Durometer type A (ADIS Gauges and Tools Manufactur ing Company, 
Mumbai) with an intender t ip Hardened steel rod 1.1 mm –  1.4 mm 
diameter.  A total o f 10samples for each group were mixed and shaped 
using stainless steel r ing molds o f inner diameter 10mm and height  
1.5mm. After 12hrs the mean hardness values o f the samples in Group I 
and Group II was 55.9100 and 57.3600 respect ively.  After 24hrs the 
mean hardness values o f the samples in  Group I and Group II was 
73.1700and 73.5000 respect ive ly.  On compar ison there was no 
stat ist ically significant  difference between the groups with p values 
0.064 and 0.545 after 12hrs and 24hrs respect ive ly.  
 
Table 1:  
Group I : zinc oxide eugeno l Group II : zinc oxide –  ozonated eugeno l 
Shore A 
Hardness 
 
No.of 
samples 
Mean 
Std. 
Deviation  
P-Value 
After 12hrs  
Group I 10 55.9 1.95587 P=.064 
NS Group II  10 57.3 1.24829 
After 24hrs  
Group I 10 73.1 .90068 P=.545 
NS Group II  10 73.5 1.43295 
 
Signif icant at the 5% level.  (p<0.05) .Statistical ly no signif icant  
difference using unpaired t’test  
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pH change of the samples  was measured using a previously calibrated 
digit al pH meter  (Eutech Instrument ,  pH tester).  A total o f three 
samples from each group were subjected to  pH test ing after  
predetermined t ime per iods: freshly mixed, 12hrs and 24hrs.  The mean 
pH values o f the freshly mixed samples in Group I and Group II was 
6.5667and 7.5667 respect ively with stat ist ically s ignificant  difference 
between them (P=.013).  Aft er  12hrs the mean pH values o f the samples 
in Group I and Group II was 6.1000 and 6.7667 respect ively with 
stat ist ically significant  difference between them (P=.007).  A fter 24hrs 
the mean pH values o f the samples in  Group I and Group II was 
5.7667and 6.2667 respect ively with no stat ist ically significant  
difference between them (P=.123).  
 
Table 2:  
Group I : zinc oxide eugeno l Group II : zinc oxide –  ozonated eugeno l 
pH of the 
test samples  
 
No of 
samples 
Mean Std. Deviation P-Value 
Freshly 
mixed 
Group I 3 6.5667 .20817 P=.013 
Sig Group II  3 7.5667 .35119 
After 12hrs  
Group I 3 6.1000 .17321 P=.007 
Sig Group II  3 6.7667 .15275 
After 24hrs  
Group I 3 5.7667 .30551 P=.123 
NS Group II  3 6.2667 .32146 
 
Signif icant at the 5% level.(p<0.05).Statistically signif icant dif ference 
using unpaired t’test in freshly mixed samples and af ter 12 
hrs.Statistically no signif icant dif ference af ter 24 hrs.  
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Solubility was tested as a percentage o f the mass o f specimen removed 
from the dist illed water compared with the or iginal mass o f the 
spec imens. 1.5 mm thick stainless steel r ing of inner  diameter 10mm 
and were used to shape the samples.  A total o f three samples from each 
group was subjected to  pH test ing after 12hrs and 24hrs.  After 12hrs 
the mean so lubilit y values o f the samples in Group I and Group II was 
0.6233and 0.6100 respect ively.  After 24hrs the mean hardness values 
of t he samples in Group I and Group II was 0 .5500 and 0.5400 
respect ively.  On compar ison there was no stat ist ically significant  
difference between the groups with p values 0.612 and 0.513 after  
12hrs and 24hrs respect ively.  
 
Table 3:  
Group I : zinc oxide eugeno l Group II : zinc oxide –  ozonated eugeno l 
Solubility of 
the test 
samples (wt%)  
 
No of 
samples 
Mean 
Std. 
Deviation  
P-Value 
After 12hrs  
Group I 3 .6233 .05033 P=.612 
NS Group II  3 .6100 .02000 
After 24hrs  
Group I 3 .5500 .02000 P=.513 
NS Group II  3 .5400 .02000 
 
Signif icant at the 5% level.(p<0.05).  Statistically no signif icant  
difference using unpaired t’test  
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Biocompatibi lity  o f the tested samples were evaluated using the MTT 
(3-(4,  5-dimethylthiazo l-2-yl)-2,  5-diphenyltet razo lium bromide)  
tet razolium reduct ion assay.  A total o f three samples from each group 
were subjected to  biocompat ibilit y test ing aft er 24hrs.  Aft er 
24hrsbiocompat ibilit y was evaluated as the percenta ge o f viabilit y o f 
mouse fibroblast  cell line L929 when test  samples were added to it . 
After 24hrs the mean biocompat ibilit y values o f the samples in Group I 
and Group II was 52.6000 and 68.4333 respect ively.  On compar ison 
there was stat ist ically significant  difference between the groups with p 
value set  at  leve l 5% after 24hrs (p=0.002).  
 
Table 4:  
Group I : zinc oxide eugeno l Group II : zinc oxide –  ozonated eugeno l 
Biocompatibi lity  
(% of viabi lity)  
 
No of 
samples 
Mean 
Std. 
Deviation  
P-Value 
After 12hrs  
Group I 3 52.6000 1.00167 P=.002 
Sig Group II  3 68.4333 1.15326 
 
Signif icant at the 5% level (p<0.05).  Statistically signif icant dif ference 
using unpaired t’test  
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Group I:  Zinc oxide eugeno l Group II:  Zinc oxide –  ozonated eugeno l 
 
Chart 1:  Hardness values of tested samples after 12hrs  
 
 
 
Chart 2:  Hardness values of tested samples after 24hrs  
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Chart 3:  Mean hardness va lues of tested samples  
 
 
 
Chart 4:  Mean pH values of tested samples  
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Chart 5:  Mean so lubilit y values o f tested samples  
 
 
 
Chart 6:  Mean biocompat ibilit y values of tested samples  
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DISCUSSION 
 Root  canal sealers along with so lid core mater ial plays a vital 
role in achieving the three dimensional sealing o f the root  canal 
system. These sealers are bind ing agents which are used to  bind the 
r igid gut ta-percha to  the canal walls and to  fill up the vo ids,  accessory 
canals and irregular it ies in the canal
1
.  Endodont ic sealers,  alt hough 
used only as adjunct ive mater ials in the obturat ion o f root  canals,  they 
also have shown to  influence the outcome of endodont ic t reatment .  A 
perfect  combinat ion o f sea ling abilit y,  ant imicrobial act ivity and 
biocompat ibilit y is what  an ideal root canal sealer should possess.  
 
An ideal root  canal sealer should possess fo llowing propert ies
1 4
.  
1.  It  should be tacky when mixed, to be able to  provide 
adhesion/sealing between the canal walls and the core obturat ing 
mater ial.  
2.  Flowabilit y in it s non-set  state to promote lut ing.  
3.  It  should be non- irr itat ing to  the per iapical t issues.  
4.  Should possess a hermet ic sealing abilit y.  
5.  It  should be radiopaque.  
6.  Minimal set t ing shr inkage.  
7.  Should be non-staining on the dent in / tooth st ructure.  
8.  It  should be ideally Bacter icidal or at -least  control Bacter ia l 
Growth. 
9.  Should have Long Working Time.  
10.Inso luble in Tissue Flu ids .  
11.It  should be easy to  remove if necessary.  
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12.It  should be neither Mutagenic nor Carcinogenic.  
13.It  should not  provoke an Immune react ion.  
 
 ZOE sealers have a history o f successful use over long per iod o f 
t ime. It  has both anaesthet ic and ant imicrobial propert ies.  The qualit y 
of the seal achieved with gut ta -percha (GP) and convent ional zinc 
oxide eugeno l (ZOE) sealers is not  quite perfect
6 8
.  Despite o f its  
advantages,  GP and convent ional sealer combinat ion st ill has it s own 
drawbacks,  like its inabilit y to  st rengthen the root ,  as it  does not 
adhere to  dent in,  inabilit y to  control micro leakage, and the so lubilit y 
of sealer makes the prognosis quest ionable
6 9
.  Also, the eugeno l 
released from ZOE is reported to  be an irr itant  to  per iapical t issues and 
has cytotoxic propert ies with limited ant imicrobial act ivity.  
 
 In search o f modern endodont ic therapeut ic modalit ies with 
efficient  and broad ant imicrobial act ivity,  ozone has proved to elicit  
super ior act ion in var ious fields o f dent ist ry.  Ozone (O 3) is an 
energised form o f oxygen and dissociates readily back to  oxygen,  
liberat ing a sing let  oxygen which is responsible for its so called 
oxidising potent ial.  Ozone is 1.6- fo ld denser and 10-fo lds more so luble 
in water (49.0 mL in 100 mL water at  0° C) when comp ared to  that  of 
oxygen. Though ozone is not  a radical molecule,  it  is t he third most 
potent  oxidant  (E_ 5 12.076 V) after fluor ine and per sulphate.  Ozone 
is an unstable gas that  cannot  be stored and should be used 
immediately because it  has a ha lf - life of 40 min at  20 °C
3 3
.  In the 
clinical set t ing,  an oxygen/ozone generator simulates lightning through 
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an electr ical discharge fie ld to generate ozone. Ozone gas has a high 
oxidising potent ial and it  is 1.5 t imes greater than chlor ide when used 
as an ant imicrobia l agent  against  bacter ia,  viruses,  fungi,  and protozoa. 
It  also has the abilit y to  st imulate blood circulat ion and the immune 
response. These features just ify t he current  interest  in it s applicat ion in 
medicine and dent ist ry and have been suggested for  t he t reatment  of 
260 different  pathologies.   
 
 There is  an evidence o f use o f ozone as a disinfectant  from 1881,  
which was ment ioned in a book on Diphther ia.  In 1893, the wor ld’s 
first  water t reatment  plant  ut ilizing ozone was installed in Ousbaden, 
Holland. Dur ing World War 1,  ozone was used medically for t reat ing 
wounds and other infect ions.  Medical grade Ozone is a combinat ion o f 
pure O2 and pure O3 in the rat io  of 0.1% to 5% of O 3  and 95%-99.5% 
of O2
7 0
.  
 
 Interest ingly enough, in 1930, a German dent ist ,  Dr. E.A. Fisch ,  
t reated Austr ian surgeon Ernst Payr for  a gangrenous pulpit is using 
ozone and thereafter inspired him to begin a new line o f researches 
dedicated to  ozone use in health care.  However,  ozone seems to have 
disappeared from pract ice in dental ca re unt il 2001 when the first  
scient ific  study was published examining the biomolecules present  in  
dental car ies,  before and after t reat ing with ozone
7 1
.  As dental 
demographics changed and in the era o f minimally invasive therapy,  
the new challenges o f managing and t reat ing an aged populat ion those 
who have retained rather than lost  their teeth needed to be addressed.  
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This was of part icular concern in reg ard to  elder ly pat ients with the 
increased suscept ibilit y o f root  surfaces car ies.  In dent ist ry,  the 
applicat ions of ozone are as fo llows
5 7
:  
1.  Reversal o f incipient  car ies.  
2.  Prevent ion o f pulpa l infect ion in deep car ies affected dent in.  
3.  Disinfect ion dur ing root  canal t reatment .  
4.  Disinfect ion o f cavit y preparat ions pr ior to  restorat ions.  
5.  Treatment  of cervical sensit ivity.  
6.  Prior to placement  of all fissure sealant .  
7.  For bleaching teeth.  
8.  Combined with other approaches to  manage car ies such as ART.  
9.  For treat ing apthus ulcer and herpes simplex lesions.  
 
 Ozone (O3) can be used in gaseous,  aqueous form or as ozonated 
oils.  In order to  control t he decomposit ion o f O 3  into oxygen it  can be 
combined with a vehicle with aqueous propert ies to improve the 
conversion more quick ly or with a vehicle with relat ively more viscous 
propert ies to  retard the conversion.  In a study conducted to  evaluate 
the biocompat ibilit y o f ozone, the aqueous form o f Ozone was found to 
be less cytotoxic than gaseous Ozone. Due to the unstable nature  of 
ozone in gaseous and aqueous form, we opted to  use ozone in the form 
of o ils.   
 
 Estrela C et  al used ozonated o ils to  ster ilize the root  canal 
systems and to clear t he canals o f necrot ic debr is by virtue o f ozone’s 
bacter icidal and effervescent  propert ies.  In t heir study they used 
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ozonated oils for dis infect ion and concluded that  irr igat ion with 
ozonated oil is more quick and efficient  in canal ster ilizat ion than that  
of convent ional irr igat ion by the sodium hypochlor it e so lut ion
7 2
.   
 
 Chandra SP et al conducted a study to evaluate the success rate 
of mixture of ozonated sesame o il and zinc oxide as a pr imary teeth 
root  filling mater ial.  They conc luded that  Ozonated sesame o il -ZnO 
demonstrated a good clinical and radiographic success rate at  12 
months fo llow-up and it  can be considered as an alt ernat ive obturat ing 
mater ial in infected pr imary teeth
7
.  
 
 Eugeno l that  has been used in dent ist ry fo r a long t ime due to  its 
analgesic and ant isept ic property is a colour less to  pale yellow o ily 
liquid extracted from certain essent ial o ils  especia lly from clove o il,  
nutmeg, cinnamon,  basil and bay leaf.  In Endodont ics studies have 
focused on the use o f ozonated water  and o ils as an intra -cana l 
medicament  and as an irr igant .  But  none of t he studies have conducted 
by ozonat ing eugeno l for being used as an endodont ic sea ler.  
 
 In the present  study, ozone was used to  overcome the drawbacks 
of ZOE sealer by bubbling ozone gas through eugeno l using an 
ozonator machine which has an output  of 400mg/hr.  The concentrat ion 
of ozone in eugeno l was checked using ozone ana lysing st r ips and was 
kept  under 0.05ppm (safety dose o f ozone as per OSHA: less t han 
0.1ppm)
7 3
.  Invit ro studies were conducted to  evaluate and compare the 
hardness,  so lubilit y,  pH and biocompat ibilit y o f conven t ional zinc 
oxide-eugeno l (Group I) and zinc oxide-ozonated eugeno l (Group II).  
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 Hardness o f t he tested samples was evaluated using Shore A 
hardness Durometer t ype A (ADIS Gauges and Tools Manufactur ing 
Company, Mumbai).  The samples were mixed as per manufacturer’s 
inst ruct ions and subjected to  hardness test ing at  the end of 24hrs and 
48hrs.  The hardness values obtained were almost  similar for both the 
groups with no stat ist ically significant  difference between them.  
(p>0.05) 
 
 pH of the mixed samples was evaluated using calibrated pH 
meter after predetermined t ime intervals (  freshly mixed, 24hrs and 
48hrs).  In Group II where eugeno l is  ozonated the pH o f freshly mixed 
samples was relat ively higher than that  o f the samples in Group I.  This 
may be due to  format ion o f hydroxyl ions readily due to the unstable 
nature of ozone.  This t rans ient  radical anion rapidly becomes 
protonated, generat ing hydrogen t rioxide (HO 3),  which, in turn,  
decomposes to  an even more powerful oxidant ,  the hydroxyl rad ical 
(OH)
5 7
.  There was stat ist ically significant  difference between the two 
groups (p < 0.05) in t he freshly mixed samples and set  samples after  
12hrs.  However  there was no stat ist ically significant  difference 
between the two groups in the set  samples after 24hrs whi ch may be 
due to the deplet ion o f singlet  oxygen with t ime.  
 
 Solubilit y o f the tested samples was evaluated by the difference 
in the percentage o f the mass o f the specimen before and after  
subject ing to  solubilit y test ing.  So lubilit y o f the tested samples  after  
12hrs and 24hrs were almost  similar in both the groups with no 
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stat ist ically significant  difference between them (p>0.05).  In this 
study, the samples in both the groups demonstrated good results,  none 
of the sealers exceeded 3% mass fract ion after immersion in water for 
24 hours,  in accordance with ISO 6876 and ANSI/ADA Specificat ions 
No. 57 and No. 30 
13
. 
 
 Biocompatibi lity  o f the tested samples was evaluated using the 
MTT (3-(4,  5-dimethylthiazo l-2-yl)-2,  5-diphenylt et razolium bromide)  
tet razolium reduct ion assay.  In the present  study biocompat ibilit y was 
evaluated as the percentage o f viabilit y of mouse fibroblast  cell line 
L929 when test  samples were added to it .  Aft er 24hrs,  the percentage 
of viabilit y was measured by recording the changes in absorbance at  
570 nm using a plate reading spectrophotometer.   
 
 In Group II where eugeno l is ozonated, there was higher 
percentage o f viabilit y when compared to  convent ional  eugeno l with 
stat ist ically significant  difference between them (p<0.05).  These 
findings were similar to  the studies of Ebensberger U  and Huth KC  in 
which a high level o f biocompat ibilit y of aqueous ozone has been 
found on human oral epithelial cells ,  ging ival fibroblast  cells,  and 
per iodontal cells
4 3
.  The metabo lic act ivity o f L-929 mouse fibroblasts 
was high when the cells were t reated with ozonated water,  whereas that  
of significant ly decreased when the cells were t reated with 2.5% 
NaOCl
5 9
.  
 
 As a response to  inflammatory process,  Ozone st imulates the 
release o f inter leukins,  leukotriene and prostaglandins,  to  promote 
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wound healing. It  act ivates mechanisms of  protein synthesis,  increases 
amount  of r ibosomes and mitochondr ia in  cells
7 4
.  These changes on the 
cellular level expla in elevat ion o f funct ional act ivity and regenerat ion  
potent ial o f t issues and organs which may account  for the increased 
percentage o f viabilit y in mouse fibroblasts when t reated with ozonated 
eugeno l.  It  also act ivates aerobic processes like glyco lys is and Krebs 
cycle at  cellular level to  st imulate blood circulat ion; hence ozone is 
also used for t reatment  of circulatory diso rders.  
 
 Ishizaki K et al explor ing the effect  of ozone on E. coli ,  they 
stated that  ozone penetrated t hrough cell membranes,  react ing with 
cytoplasmic contents,  cleaving the circular plasmid DNA,  thus 
impair ing bacter ial procreat ion. They also stated that  higher organisms 
have developed mechanisms for protect ing  DNA and repair ing them 
when disrupted while subject ing to  ozone therapy
7 5
.  This could provide 
a part ial exp lanat ion for why ozone at  doses prescr ibed, is toxic to 
pathogens and not  to  the healthy cells and these features just ify t he 
current  interest  in its app licat ion in dent ist ry.  
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SUMMARY AND CONCLUSION 
 
 Dent ist ry is  changing, as we are now using  modern science to 
pract ice dent ist ry.  In Endodont ics,  the sealers are responsible for the 
pr incipal funct ions o f the final root  filling: sealing o ff o f the root cana l 
system, entombment  of remaining bacter ia and the filling o f 
irregular it ies in t he prepared canal.  The Zinc Oxide Eugeno l (ZOE) 
based sealers were introduced in Endodont ics by Grossman  in 1936.  
ZOE sealers have a history o f successful use over extended per iod of 
t ime.  However it s  use has been rest r icted in recent  years due to  its few 
drawbacks including the cytotoxic and ir r itat ing property o f eug eno l
3
.  
Eugeno l (4- acyl-2-methoxy pheno l) is  an extract  of clove (Eugenia 
caryophyllata) commonly used as an anaesthet ic and ant imicrobial 
agent  in the field o f medic ine and dent ist ry.   
 
 Several at tempts that  have been made to  overcome these 
disadvantages have failed and there is cont inued research for chemical 
compounds with bet ter physical propert ies and biocompat ibilit y.  The 
evo lut ion o f sealers is from the convent ional ZOE to the contemporary 
ones like epoxy-based resin and methacrylate - resin based sealers,  and 
to  the most  recent  MTA sealer and bioceramic sealer.  However t il l 
date,  none o f the sealers has proved to be the ideal except  a few which 
can come c loser to  being one.  
 
 Cons ider ing the beneficial effects of eugeno l with few 
drawbacks,  we decided to  improve it s propert ies by other modalit ies.  In 
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search o f other t reatment  modalit ies,  ozone therapy has a long history 
of research and clinical applicat ions with humans because o f its  
int erest ing bio logical propert ies.  In Endodont ics studies have focused 
on the use o f ozonated water and o ils as an intra -canal medicament  and 
as an irr igant .  But  none o f the studies have conducted by ozonat ing 
eugeno l for being used as an endodont ic  sealer.  In the present  study,  
ozone was used to  overcome the drawbacks o f ZOE sealer by bubbling 
ozone gas through eugeno l using an ozonator machine.  
 
 In vit ro lab test ing was done to  evaluate and compare the 
phys ical propert ies and biocompat ibilit y of z inc oxide eugeno l (Group 
I) and z inc oxide- ozonated eugeno l (Group II). The proport iona l 
values obtained were tabulated and stat ist ically analysed by unpaired t  
test .  Solubilit y and hardness o f the tested samples were almost  similar  
in both the groups wit h no stat ist ical difference between them.  pH o f 
freshly mixed samples in Group II was relat ively higher than the 
samples in Group I which may due to the increased format ion o f 
hydroxyl ions.   
 
 Biocompat ibilit y o f t he tested samples in Group II was 
comparat ively more than that  of the samples in Group I.  The increased 
percentage o f viabilit y may be due to  the act ivat ion o f protein 
synthesis,  increased amount  of r ibosomes and mitochondr ia synthesis 
in ce lls.  These changes on the ce llular level expla in the ele vat ion o f 
funct ional act ivity and regenerat ion potent ial o f t issues and organs.  
Ozone br ings about  the r ise o f pO 2  in t issues and improves 
Summary and Conclusion  
 
62 
t ransportat ion o f oxygen in blood, which result s in change o f cellular 
metabo lism –  act ivat ion o f aerobic processes (glyco lys is,  β-oxidat ion 
of fat ty ac ids and Krebs cycle) and use o f energet ic resources.  
  
 Within the limitat ions o f the study, it  can be concluded that 
consider ing the beneficia l propert ies o f eugeno l with few drawbacks:  
ozone with interest ing bio logical propert ies seems to be a bet ter 
t reatment  modalit y in improving the propert ies o f eugeno l.  However  
further  clinical t r ials and randomized control studies are required in 
this field to  use ozonated eugeno l in combinat ion with zinc oxide 
powder to use it  as an endodont ic sealer invivo.  
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